STIM
Neuronetics, Inc.
+0.18 (+6.52%)2.94USD406K成交股數224M市值–本益比(近四季)1.4股價營收比+9.1%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 41.6M+30% | 34.5M+53% | 37.3M+101% | 38.1M+132% | 32.0M+84% | 22.5M+30% | 18.5M+5% | 16.5M+6% | 17.4M | 17.4M | 17.6M | 15.5M |
| 營業成本 | 20.3M | 18.3M | 20.2M | 20.4M | 16.2M | 7.6M | 4.5M | 4.3M | 4.3M | 6.1M | 4.8M | 4.1M |
| 毛利 | 21.2M+35% | 16.2M+8% | 17.1M+22% | 17.8M+46% | 15.7M+20% | 14.9M-1432% | 14.0M+10% | 12.2M+7% | 13.1M | −1.1M | 12.8M | 11.4M |
| 毛利率 | 51.1% | 46.9% | 45.9% | 46.6% | 49.2% | 66.2% | 75.6% | 74.0% | 75.1% | -6.4% | 72.5% | 73.3% |
| 研發費用 | 1.3M | 1.4M | 1.5M | 1.8M | 1.6M | 5.8M | 2.4M | 2.2M | 2.3M | 138K | 2.4M | 2.8M |
| 銷售管理費用 | 11.4M | 13.0M | 11.1M | 12.2M | 13.1M | 11.9M | 6.3M | 6.1M | 6.0M | 6.0M | 6.2M | 6.6M |
| 營業利益 | −1.5M-86% | −9.0M-22% | −7.3M-5% | −8.1M-5% | −11.0M+61% | −11.5M+29% | −7.7M+5% | −8.5M-14% | −6.9M | −8.9M | −7.3M | −9.9M |
| 營業利益率 | -3.6% | -26.1% | -19.6% | -21.1% | -34.4% | -51.0% | -41.7% | -51.7% | -39.4% | -51.1% | -41.7% | -63.8% |
| 稅後淨利 | −3.4M-73% | −10.8M-15% | −9.0M-32% | −10.1M+3% | −12.7M+61% | −12.7M-6% | −13.3M+172% | −9.8M-7% | −7.9M | −13.5M | −4.9M | −10.5M |
| 淨利率 | -8.3% | -31.3% | -24.3% | -26.6% | -39.6% | -56.3% | -72.0% | -59.8% | -45.2% | -77.7% | -27.8% | -67.7% |
| 稀釋 EPS | -0.05-76% | -0.16-53% | -0.13-70% | -0.15-55% | -0.21-22% | -0.34+6% | -0.44+159% | -0.33-13% | -0.27 | -0.32 | -0.17 | -0.38 |
| 稀釋股數 | 73.1M | 69.6M | 67.3M | 66.2M | 61.5M | 31.7M | 30.3M | 30.1M | 29.5M | 42.2M | 28.6M | 28.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.2M | 13.2M | 28.0M | 11.0M | 20.2M | 18.5M | 20.9M | 42.6M | 47.7M | 35.8M | 45.9M | 55.4M |
| 應收帳款 | 16.0M | 15.8M | 18.7M | 26.1M | 26.2M | 23.4M | 12.6M | 17.1M | 17.5M | 15.0M | 13.1M | 9.5M |
| 存貨 | 5.5M | 4.7M | 4.3M | 4.9M | 4.1M | 4.2M | 5.0M | 6.1M | 6.7M | 9.7M | 8.9M | 9.1M |
| 總資產 | 132M | 125M | 145M | 135M | 142M | 141M | 49.9M | 96.8M | 104M | 93.0M | 100M | 104M |
| 有息負債 | 61.5M | 61.3M | 65.7M | 55.5M | 55.3M | 55.2M | 46.0M | 46.1M | 59.4M | 36.9M | 36.7M | 36.6M |
| 總負債 | 110M | 108M | 114M | 103M | 102M | 109M | 190M | 77.4M | 76.2M | 55.0M | 54.9M | 55.3M |
| 股東權益 | 17.9M | 13.3M | 27.4M | 27.1M | 35.5M | 27.7M | −137M | 19.4M | 27.7M | 37.9M | 45.5M | 48.3M |
| 負債比 | 83.5% | 86.4% | 78.4% | 76.6% | 72.2% | 77.4% | 381.7% | 80.0% | 73.4% | 59.2% | 54.7% | 53.3% |
| 淨現金(現金 − 有息負債) | −42.3M | −48.1M | −37.7M | −44.6M | −35.1M | −36.7M | −25.1M | −3.5M | −11.7M | −1.0M | 9.2M | 18.8M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.4M | – | – | −17.0M+41% | – | – | – | −12.0M | – | – | −15.2M |
| 資本支出 | – | 197K | – | – | 219K | – | – | – | 375K | – | – | 234K |
| 自由現金流 | – | −9.6M | – | – | −17.2M+39% | – | – | – | −12.4M | – | – | −15.4M |
| 折舊攤銷 | 400K | 745K | 500K | 500K | 911K | 413K | 500K | 600K | 560K | 500K | 500K | 516K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -27.9% | – | – | -53.8% | – | – | – | -71.1% | – | – | -99.4% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 149M
| Clinical Services | 87.0M | 58.3% | +1856.7% |
|---|---|---|---|
| Medical Device | 62.2M | 41.7% | -11.7% |
產品／服務2025 年度 · 149M
| 服務 | 87.0M | 58.3% | +1856.7% |
|---|---|---|---|
| 產品 | 62.2M | 41.7% | -11.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 149M | +99.2% | −39.0M | -26.1% | -0.59 | −21.2M |
| FY2024 | 74.9M | +5.0% | −43.7M | -58.4% | -1.38 | −32.5M |
| FY2023 | 71.3M | +9.4% | −30.2M | -42.3% | -1.05 | −34.4M |
| FY2022 | 65.2M | +17.9% | −37.2M | -57.0% | -1.38 | −34.0M |
| FY2021 | 55.3M | +12.3% | −31.2M | -56.4% | -1.22 | −30.3M |
| FY2020 | 49.2M | -21.4% | −27.5M | -55.7% | -1.46 | −29.1M |
| FY2019 | 62.7M | +18.7% | −29.0M | -46.4% | -1.58 | −31.3M |
| FY2018 | 52.8M | – | −24.1M | -45.7% | -2.69 | −21.6M |